O
AMAG

OppenheimerFunds’s AMAG Pharmaceuticals AMAG Stock Holding History

OppenheimerFunds’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$306K Buy
23,752
+6,289
+36% +$93.7K ﹤0.01% 1541
2018
Q4 		$265K Sell
17,463
-360
-2% -$6.86K ﹤0.01% 1622
2018
Q3 		$356K Buy
17,823
+2,038
+13% +$46.4K ﹤0.01% 1580
2018
Q2 		$308K Sell
15,785
-2,982
-16% -$66K ﹤0.01% 1625
2018
Q1 		$378K Sell
18,767
-9,352
-33% -$158K ﹤0.01% 1508
2017
Q4 		$373K Buy
28,119
+7,797
+38% +$118K ﹤0.01% 1613
2017
Q3 		$375K Sell
20,322
-6,216
-23% -$116K ﹤0.01% 1637
2017
Q2 		$488K Buy
26,538
+8,963
+51% +$178K ﹤0.01% 1513
2017
Q1 		$396K Buy
17,575
+8,836
+101% +$212K ﹤0.01% 1600
2016
Q4 		$304K Buy
8,739
+75
+0.9% +$2.24K ﹤0.01% 1590
2016
Q3 		$212K Sell
8,664
-735
-8% -$18.4K ﹤0.01% 1635
2016
Q2 		$225K Buy
+9,399
New +$215K ﹤0.01% 1574

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OppenheimerFunds's AMAG Position: Q1 2019 in Review

OppenheimerFunds increased its AMAG Pharmaceuticals (AMAG) stake by 36% in Q1 2019, buying an estimated $93.7K and bringing the position to 23,752 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

OppenheimerFunds first reported a position in AMAG in Q2 2016 and has held it in 12 quarters since. The position peaked at $488K in Q2 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • OppenheimerFunds held 23,752 shares of AMAG Pharmaceuticals worth $306K as of Q1 2019.
  • OppenheimerFunds bought 6,289 AMAG Pharmaceuticals shares in Q1 2019, an estimated $93.7K.
  • AMAG Pharmaceuticals made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1541 holding.
  • OppenheimerFunds first reported a position in AMAG Pharmaceuticals in Q2 2016 and has held it in 12 quarters since.
  • OppenheimerFunds's AMAG Pharmaceuticals position peaked at $488K in Q2 2017.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.